Related Experiment Video
Updated: May 24, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution
Daniel J Callahan1, Wenge Liu, Xinghai Li
1Department of Biomedical Engineering, Duke University, 136 Hudson Hall, Box 90281, Durham, North Carolina 27708, USA.
Researchers developed novel pH-responsive polypeptide micelles that break apart in acidic tumor environments. This targeted drug delivery system shows improved tumor penetration and distribution compared to non-responsive controls.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery
Background:
- Nanoparticle drug delivery faces challenges with limited tumor penetration.
- Tumor microenvironments often exhibit lower extracellular pH compared to normal tissues.
Purpose of the Study:
- To develop the first pH-responsive polypeptide micelle for enhanced tumor drug delivery.
- To investigate micelle dissociation at the acidic pH characteristic of solid tumors.
Main Methods:
- Self-assembly of histidine-rich elastin-like polypeptide block copolymer into micelles at 37 °C.
- Stabilization of micelles using Zn(2+).
- Assessment of micelle disruption at pH 6.4 compared to pH 7.4.
Main Results:
- Spherical micelles were formed and stabilized by Zn(2+).
- Micelles demonstrated pH-dependent dissociation, disrupting as pH decreased from 7.4 to 6.4.
- In vivo studies showed superior tumor penetration and distribution for pH-sensitive micelles over controls.
Conclusions:
- pH-responsive polypeptide micelles offer a promising strategy to overcome nanoparticle tumor penetration limitations.
- Targeted micelle dissociation at tumor-specific pH enhances drug delivery efficacy.
- This approach represents a significant advancement in targeted cancer nanotherapeutics.
More Related Videos
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted

